Application 019886
- Type
- NDA
- Sponsor
- GD SEARLE LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SYNAREL | NAFARELIN ACETATE | SPRAY, METERED;NASAL | EQ 0.2MG BASE/SPRAY | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019886-001 | SYNAREL | NAFARELIN ACETATE | EQ 0.2MG BASE/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 1990-02-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N019886-001 | SYNAREL | EQ 0.2MG BASE/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 1990-02-13 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N019886-001 | SYNAREL | EQ 0.2MG BASE/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 1990-02-13 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N019886-001 | SYNAREL | EQ 0.2MG BASE/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 1990-02-13 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N019886-001 | SYNAREL | EQ 0.2MG BASE/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 1990-02-13 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Synarel | NAFARELIN ACETATE | Pfizer Laboratories Div Pfizer Inc | d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6 | 2026-03-05 | Warnings, Adverse reactions | 019886 NDA019886 0025-0166 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0025-0166 | Synarel | nafarelin acetate | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-0166 | Synarel | nafarelin acetate | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-0166 | Synarel | nafarelin acetate | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-0166 | Synarel | nafarelin acetate | G.D. Searle LLC Division of Pfizer Inc | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84310 | SUPPL | 2025-11-25 |
| 84303 | SUPPL | 2025-11-25 |
| 84302 | SUPPL | 2025-11-25 |
| 73402 | SUPPL | 2023-02-07 |
| 73355 | SUPPL | 2023-02-01 |
| 70831 | SUPPL | 2022-04-27 |
| 70830 | SUPPL | 2022-04-27 |
| 70807 | SUPPL | 2022-04-26 |
| 48496 | SUPPL | 2017-05-23 |
| 48495 | SUPPL | 2017-05-23 |
| 48480 | SUPPL | 2017-05-22 |
| 48479 | SUPPL | 2017-05-22 |
| 48478 | SUPPL | 2017-05-22 |
| 48477 | SUPPL | 2017-05-22 |
| 19793 | SUPPL | 2015-08-11 |
| 11814 | SUPPL | 2015-08-10 |
| 1764 | SUPPL | 2012-01-17 |
| 34068 | SUPPL | 2012-01-12 |
| 34067 | SUPPL | 2011-01-11 |
| 11813 | SUPPL | 2011-01-11 |
| 19792 | SUPPL | 2011-01-07 |
| 1763 | SUPPL | 2011-01-07 |
| 34066 | SUPPL | 2006-04-13 |
| 1762 | SUPPL | 2006-04-13 |
| 20406 | SUPPL | 1999-07-21 |
| 1761 | SUPPL | 1998-12-24 |